Remote Monitoring

Remote cardiac monitoring technologies enable patient health to be tracked outside the clinical setting. It can be used for longer term monitoring to help diagnosis arrhythmias or other cardiac conditions. Remote monitoring also can keep tabs on chronic conditions such as heart failure or hypertension and alert clinicians to worsening symptoms to avoid an acute care episode or hospitalization.

RSS icon
the words "FDA recall" on a board

Medtronic recalls nearly 350,000 implantable heart devices after 22 injuries

The FDA has categorized this as a Class I recall, meaning the use of these devices could cause “serious injuries or death.”

dissolvable heart monitors for AFib designed by Northwestern and George Washington

New dissolvable heart monitors could help cardiologists battle AFib

The new-look devices are soft, flexible, transparent and roughly the size of a postage stamp.

FDA approves Abbott’s Aveir dual chamber (DR) leadless pacemaker system, the world’s very first dual chamber leadless pacing solution for treating patients with abnormal heart rhythms.

FDA approves world’s first dual-chamber leadless pacemaker system

The minimally invasive system is made up of two pacemakers that send signals back and forth to one another. One pacemaker is placed on the patient's right ventricle, and the other is placed on the patient's right atrium. 

healthcare value value-based care money dollar

Abbott awards $2.6M to American Diabetes Association for CGM research

The three-year grant will help the ADA fund two pilot programs and engage with healthcare professionals and other industry leaders.

Thumbnail

‘Notably high’ rates of PTSD, depression and anxiety seen in patients with implantable heart devices

"Psychologists have had little involvement in the care of cardiac patients but this needs to change," one researcher said in a statement. 

Zio AT mobile cardiac telemetry device

FDA warning letter: iRhythm committed multiple violations, failed to report patient deaths in time

“It is your firm’s responsibility to ensure compliance with applicable laws and regulations administered by FDA,” according to the warning letter. These issues, the agency added, “may be symptomatic of serious problems in your firm’s manufacturing and quality management systems.”

Kenneth Ellenbogen, MD, explains the key EP takeaways from the 2023 Heart Rhythm Society meeting.

Key takeaways from Heart Rhythm 2023

Kenneth Ellenbogen, MD, detailed some of the biggest trends he saw at the three-day event in New Orleans. 

The proliferation of artificial intelligence (AI) in healthcare includes numerous algorithms for electrophysiology (EP). Jagmeet Singh, MD, Professor of Medicine, Harvard Medical School, and founding director of the Resynchronization and Advanced Cardiac Therapeutics Program and Mass General Hospital, spoke with Cardiovascular Business at Heart Rhythm 2023 to explain how AI is being used in EP. #HRS2023 #HRS #AI

AI gaining popularity in electrophysiology

There are now numerous AI algorithms for electrophysiology. Jagmeet Singh, MD, examined how this advanced technology is being applied.

Displaying 49 - 56 of 130

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Design by Adaptive Theme
Trimed Popup
Trimed Popup